INDUSTRY × Observational × Carcinoma, Hepatocellular × Clear all cfDNA Methylation for Liver Cancer Recurrence Detection
Recruiting
500 enrolled
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
Recruiting
5,000 enrolled
A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice
Recruiting
700 enrolled
IMreal
Active not recruiting
2,756 enrolled
CCANED-CIPHER
Recruiting
6,000 enrolled
ELEPHAS-02
Recruiting
416 enrolled
Imjudo & Imfinzi PMS
Recruiting
246 enrolled
ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk
Active not recruiting
2,990 enrolled
BRA-HEP
Completed
300 enrolled
EchoTip AcuCore Post-Market Clinical Study
Completed
183 enrolled
TraveraRTGx
Recruiting
200 enrolled
HIDE
Recruiting
200 enrolled
Retrospective Study of Long-Term Survival of "Immuncell-LC" in Patients Undergoing Curative Resection for HCC in Korea
Completed
230 enrolled
Hepatocellular Carcinoma 3 Gene Methylation Combination Detection Kit (PCR Fluorescent Probe Method) Multicenter Clinical Trial
Active not recruiting
900 enrolled
LOCUS
Not yet recruiting
64 enrolled
JADE
Recruiting
1,000 enrolled
Retrospective Clinical Validation of HepatoPredict
Not yet recruiting
200 enrolled
Case-Control Study of the Glycotestâ„¢ HCC Panel Vs AFP for the Detection of Early-stage Hepatocellular Carcinoma
Active not recruiting
766 enrolled
TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA.
Completed
6 enrolled 15 charts
K-DETEK
Completed
9,057 enrolled
Observational Study for SIR-Spheres Therapy for the Treatment of HCC Patients in China
Enrolling by invitation
100 enrolled
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Withdrawn
MYCOS
Completed
40,110 enrolled
HEPATIC
Completed
1,556 enrolled
HCC Screening Using DNA Methylation Changes in ctDNA
Completed
403 enrolled 11 charts
LIVER-1
Recruiting
1,200 enrolled
Post-marketing Surveillance on the Safety of CabometyxTM in Korean Patients
Completed
347 enrolled
Cell-free DNA From Junction of Hepatitis B Virus Integration in HCC Patients for Monitoring Post-resection Recurrence
Completed
207 enrolled
Refinement and Validation of a Diagnostic Model (GAMAD) for Early Detection of Hepatocellular Carcinoma
Recruiting
2,000 enrolled
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated Primary Liver Cancer
Withdrawn
Safety and Effectiveness of BioTraceIO Lite for Tissue Damage Assessment Following Liver Tissue Ablation Procedures
Completed
65 enrolled
A Study of Lenvima (Lenvatinib) in Korean Unresectable Hepatocellular Carcinoma (uHCC) Participants
Completed
658 enrolled
GNB4 and Riplet Gene Methylation Combined Detection Kit (Fluorescence PCR Method)
Unknown
1,000 enrolled
Breath Test to Assess Hepatic Metabolic Reserve and to Predict Hepatic Decompensation in Cirrhotics
Terminated
200 enrolled
Direct Acting Antiviral-Post Authorization Safety Study
Completed
42 enrolled
Characterization of Methylation Patterns in Hepatocellular Carcinoma
Terminated
120 enrolled
TARGET
Completed
209 enrolled
Hope166
Terminated
20 enrolled
A Post-marketing Observational Study on Risk Factors for Hepatic Encephalopathy in Participants With Unresectable Hepatocellular Carcinoma
Completed
713 enrolled
PIONEER
Unknown
1,000 enrolled
SORAGO-HCC
Terminated
3 enrolled
HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC)
Completed
175 enrolled
LifePearl Anthracyclin Registry in Selective Chemo-Embolization of Patients With Unresectable HCC (PARIS Registry)
Completed
102 enrolled
A Study to Assess Overall Survival and Treatment Patterns for Advanced Liver Cancer Participants Who Received Nivolumab Therapy
Completed
1,426 enrolled
Hepatocellular Carcinoma Registry for Turkey (3K Trial)
Completed
600 enrolled
Circulating Tumor DNA Exposure in Peripheral Blood
Unknown
10,000 enrolled
OPTIMIS
Completed
1,676 enrolled
Post-marketing Surveillance of DC Bead in Patients With Hepatocellular Carcinoma
Completed
300 enrolled
SUCCESS
Completed
302 enrolled
SECURE
Completed
106 enrolled